Optibiotix Health Plc

Company Profile

Company website
Pharmaceuticals & Biotechnology (Biotechnology)

OptiBiotix Health plc (AIM: OPTI) develops compounds which modify the human microbiome - the collective genome of the microbes in the body - to prevent and manage human disease.

Investor Access

26 Jul
Event information

2023 Annual General Meeting

(please check the link for more information: https://www.londonstockexchange.com/news-article/OPTI/final-results/16017101)   

Walbrook PR Ltd, 75 King William Street, London, EC3V 9HD
Wednesday, 26 July 2023 at11.00 am
Financial Calendar
 Event  Date
Year End 31 December
Half  Year End 30 June
Preliminary Results* May
Interim Results* September
AGM* July

* Months based on previous announcements of this kind